These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3918691)

  • 41. Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting.
    Wilder-Smith C; Schimke J; Vergin H; Senn HJ
    Arzneimittelforschung; 1989 Nov; 39(11):1464-7. PubMed ID: 2619781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical pharmacokinetics of high-dose metoclopramide in cancer patients receiving cisplatin therapy.
    McDermed JE; Cohen JL; Joseph C; Strum SB
    J Clin Oncol; 1985 Oct; 3(10):1400-8. PubMed ID: 3900303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiemetic activity of high doses of metoclopramide combined with methylprednisolone versus metoclopramide alone in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
    Roila F; Tonato M; Basurto C; Bella M; Passalacqua R; Morsia D; DiCostanzo F; Donati D; Ballatori E; Tognoni G
    J Clin Oncol; 1987 Jan; 5(1):141-9. PubMed ID: 3543234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adrenocorticotropic hormone in the prevention of cisplatin-induced nausea and vomiting.
    Colbert N; Izrael V; Lotz JP; Stoppa-Lyonnet D; Vannetzel JM; Pene F; Schlienger M; Laugier A
    J Clin Oncol; 1983 Oct; 1(10):635-9. PubMed ID: 6321674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.
    Presant CA; Wiseman C; Gala K; Kennedy P; Bouzaglou A; Blayney D; Schindler J; Rigas M; Melville J; Dolan J
    Prog Clin Biol Res; 1987; 248():299-302. PubMed ID: 3671417
    [No Abstract]   [Full Text] [Related]  

  • 46. The value of dexamethasone when added to combination drug therapy in the prevention of cisplatin-induced nausea and vomiting, evaluated by time-lapse video technology.
    Rhinehart SN; Dugan WM; Parashos PJ; Triplett WC; Minnick DJ; Fry MW
    Prog Clin Biol Res; 1986; 216():407-16. PubMed ID: 3523534
    [No Abstract]   [Full Text] [Related]  

  • 47. Effective control of moderate-dose cisplatin-induced emesis by a short-course regimen including metoclopramide, chlorpromazine and hydrocortisone: results of a randomized trial with metoclopramide alone.
    Pollera CF; Calabresi F
    Oncology; 1989; 46(4):238-44. PubMed ID: 2740067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
    Senn HJ; Glaus A; Bachmann-Mettler I
    J Clin Oncol; 1984 Apr; 2(4):320-2. PubMed ID: 6538593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pentobarbital's effect in a combination antiemetic regimen for cisplatin induced nausea and vomiting.
    Wheelock JB
    J Miss State Med Assoc; 1989 Jan; 30(1):5-8. PubMed ID: 2647995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
    Bishop JF; Olver IN; Wolf MM; Matthews JP; Long M; Bingham J; Hillcoat BL; Cooper IA
    J Clin Oncol; 1984 Jun; 2(6):691-5. PubMed ID: 6374058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiemetics for patients treated with antitumor chemotherapy.
    Williams CJ; Bolton A; de Pemberton R; Whitehouse JM
    Cancer Clin Trials; 1980; 3(4):363-7. PubMed ID: 6253100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
    Martín M; Díaz-Rubio E
    Med Clin (Barc); 1989 Jun; 93(2):50-3. PubMed ID: 2755259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, double-blind cross-over study of acute cisplatin-induced nausea and vomiting, comparing a new schedule of the combination of metoclopramide and methylprednisolone versus metoclopramide alone.
    Díaz-Rubio E; González-Larriba JL; Rosell R; Abad A; Martín M; Valerdi JJ; Barriga JJ
    Ann Oncol; 1990 Sep; 1(5):379-80. PubMed ID: 2261379
    [No Abstract]   [Full Text] [Related]  

  • 54. High-dose metoclopramide in cancer chemotherapy-induced nausea and vomiting.
    Bui NB; Marit G; Hoerni B
    Cancer Treat Rep; 1982 Dec; 66(12):2107-8. PubMed ID: 7139655
    [No Abstract]   [Full Text] [Related]  

  • 55. A double-blind comparison of domperidone and metoclopramide suppositories in the treatment of nausea and vomiting in children.
    Van Eygen M; Dhondt F; Heck E; Ameryckx L; Van Ravensteyn H
    Postgrad Med J; 1979; 55 Suppl 1():36-9. PubMed ID: 382153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
    Aapro MS; Plezia PM; Alberts DS; Graham V; Jones SE; Surwit EA; Moon TE
    J Clin Oncol; 1984 May; 2(5):466-71. PubMed ID: 6539363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial comparing two short courses of moderate-dose metoclopramide for moderate-dose cisplatin-induced emesis.
    Pollera CF; Conti EM; De Nigris A; Calabresi F
    Oncology; 1987; 44(2):73-7. PubMed ID: 3554084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Improved control of cisplatin-induced emesis with high-dose metoclopramide, dexamethasone and lorazepam].
    Mau YK; Li YT; Tsui MS; Tu FC; Hsu KP
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):116-20. PubMed ID: 1848133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin].
    Yoshiya N; Kodama S; Tanaka K; Hataya I; Tokunaga A; Takeuchi Y; Hanaoka J; Yanase T; Takahashi T; Maruhashi T
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1641-6. PubMed ID: 8060140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
    Gez E; Ben-Yosef R; Catane R; Brufman G; Biran S
    Oncology; 1989; 46(3):150-4. PubMed ID: 2654792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.